Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates
- 8 July 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 49 (3) , 179-182
- https://doi.org/10.1016/j.diagmicrobio.2004.04.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Medical management of pulmonary disease caused by Mycobacterium avium complexClinics in Chest Medicine, 2002
- Epidemiology of human pulmonary infection with mycobacteria nontuberculousClinics in Chest Medicine, 2002
- Kanamycin Susceptibility Testing of Mycobacterium tuberculosis Using Mycobacterium Growth Indicator Tube and a Colorimetric MethodAntimicrobial Agents and Chemotherapy, 2001
- Rapid, Efficient Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Sputum by Microscopic Observation of Broth CulturesJournal of Clinical Microbiology, 2000
- Molecular basis of clarithromycin-resistance in Mycobacterium avium–intracellulare complexTubercle and Lung Disease, 2000
- Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1997
- Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complexJournal of Medical Microbiology, 1996
- Clarithromycin in the Treatment of Mycobacterium avium Lung Infections in Patients Without AIDSChest, 1995
- Bioluminescence method to evaluate antimicrobial agents against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1995
- Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex DiseaseAnnals of Internal Medicine, 1994